Testing effectiveness (Phase 2)UnknownNCT01154387
What this trial is testing
Evaluating Safety and Efficacy of TOL101 Induction Versus Anti-Thymocyte Globulin to Prevent Kidney Transplant Rejection
Who this might be right for
End Stage Renal DiseaseRenal Transplant
Tolera Therapeutics, Inc 85